DUBLIN, Dec. 30, 2019 /PRNewswire/ — The “Biological Safety Testing Products & Services Market Analysis Report By Product (Reagents & Kits, Instruments, Services), By Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), By Test By Region, And Segment Forecasts, 2019 – 2026” report has been added to ResearchAndMarkets.com’s offering.
The global biological safety testing products and services market size is expected to reach a value of USD 6.9 billion by 2026, exhibiting a CAGR of 12.3%
The market is predominantly driven by increasing production of biologics, which is boosting the need for highly efficient biological safety testing tools. Rising disease burden is expected to be a major factor responsible for high production of biologics, thereby contributing to market growth.
Increasing prevalence of lifestyle-associated chronic diseases such as cancer and diabetes is a key factor contributing to rise in drug development and subsequent commercialization. This is expected to increase the need for scrutinizing